| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.084 | 0.1 |